Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a natural antisense transcript located opposite the DPY19L1 gene (ENSG00000146006), which encodes a conserved multi-transmembrane protein involved in neuronal migration and cell development[1][3]. Antisense transcripts like this are non-coding RNAs that can regulate the expression of their sense (protein-coding) counterparts through epigenetic, transcriptional, or post-transcriptional mechanisms, including modulation of chromatin architecture, mRNA stability, or transcriptional interference[2][4]. The functional roles of such antisense transcripts are an area of active research. There is currently no evidence this particular antisense transcript constitutes a canonical therapeutic target or has a direct role in human disease, nor are there any drugs known to act upon it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural antisense transcript to DPY19L1.